Etravirine

CAS No. 269055-15-4

Etravirine ( R-165335;TMC-125 )

Catalog No. M13823 CAS No. 269055-15-4

A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 In Stock
5MG 61 In Stock
10MG 102 In Stock
25MG 178 In Stock
50MG 264 In Stock
100MG 363 In Stock
200MG 460 In Stock
500MG 746 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Etravirine
  • Note
    Research use only, not for human use.
  • Brief Description
    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.
  • Description
    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.HIV Infection Approved
  • Synonyms
    R-165335;TMC-125
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    ReverseTranscriptase
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    269055-15-4
  • Formula Weight
    435.28
  • Molecular Formula
    C20H15BrN6O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    N#CC1=CC(C)=C(OC2=NC(NC3=CC=C(C#N)C=C3)=NC(N)=C2Br)C(C)=C1
  • Chemical Name
    Benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Das K, et al. J Med Chem, 2004, 47(10), 2550-2560.
2. Andries K, et al. Antimicrob Agents Chemother. 2004 Dec;48(12):4680-6.
3. Sankatsing SU, et al. AIDS. 2003 Dec 5;17(18):2623-7.
molnova catalog
related products
  • Escin IA;Aescin IA

    Escin IA is a triterpene saponin isolated from horse chestnut which inhibits HIV-1 protease with IC50 values of 35 μM. Escin IA has anti-TNBC metastasis activity and its action mechanisms involved inhibition of epithelial-mesenchymal transition process by down-regulating LOXL2 expression.

  • DMJ-I-228

    A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.

  • DRB

    DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).